Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 59651-167

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 59651-167). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (100 mg/150 mg (30 Tablets Bottle))

Package Label-principal Display Panel (100 mg/150 mg (30 Tablets Bottle))
Label for Emtricitabine and Tenofovir Disoproxil Fumarate tablets 100 mg/150 mg, film-coated oral tablets, distributed by Aurobindo Pharma USA, Inc. The package contains 30 tablets. The label includes storage instructions, dosage directions, barcode, and manufacturing information indicating the product is made in India by Aurobindo Pharma Limited.*
FDA Label Image

Package Label-principal Display Panel (133 mg/200 mg (30 Tablets Bottle))

Package Label-principal Display Panel (133 mg/200 mg (30 Tablets Bottle))
Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 133 mg/200 mg film-coated tablets. The label shows the product name, strengths, oral route, quantity of 30 tablets, and distribution by Aurobindo Pharma USA, Inc. It includes storage instructions and dispensing guidance, stating the product is made in India by Aurobindo Pharma Limited.*
FDA Label Image

Package Label-principal Display Panel (167 mg/250 mg (30 Tablets Bottle))

Package Label-principal Display Panel (167 mg/250 mg (30 Tablets Bottle))
Packaging label for Emtricitabine and Tenofovir Disoproxil Fumarate film-coated tablets, strength 167 mg/250 mg, in a package of 30 tablets. The label indicates the product is distributed by Aurobindo Pharma USA, Inc., made in India, with storage instructions and a barcode on the right side. The label includes dosage information and a pharmacist dispensing note.*
FDA Label Image

Structure1 (Emtriteno Str1)

Structure1 (Emtriteno Str1)
Chemical structure of Emtricitabine, one active ingredient in Emtricitabine and Tenofovir Disoproxil Fumarate oral tablets by Aurobindo Pharma Limited.*
FDA Label Image

Structure2 (Emtriteno Str2)

Structure2 (Emtriteno Str2)
Chemical structure of the active ingredient Emtricitabine and Tenofovir Disoproxil Fumarate, showing the molecular arrangement and bonding typical for this combination drug used in oral tablet form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.